Linc00205/Mir-495-3p/Tnfsf15 Axis is Implicated in the Treatment Effect of Hyperbaric Oxygen Therapy on Patients with Post-Stroke Cognitive Impairment.
{"title":"Linc00205/Mir-495-3p/Tnfsf15 Axis is Implicated in the Treatment Effect of Hyperbaric Oxygen Therapy on Patients with Post-Stroke Cognitive Impairment.","authors":"Xiaoling Yang, Miao Chen, Zuoting Shen, Tianyi Rong, Jialiang Feng, Min Wu, Deyan Chen, Zhenyu Wei","doi":"10.29399/npa.28530","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We investigated the effects of hyperbaric oxygen (HBO) therapy on post-stroke cognitive impairment (PSCI) and performed the differential profiling of lncRNAs and mRNA.</p><p><strong>Methods: </strong>The serum levels of different inflammatory factors were detected in PSCI patients with or without HBO therapy. The cognitive functions of patients in different groups were assessed before and after treatment. Differential expression analysis was performed on lncRNAs and mRNAs, followed by functional interaction prediction. The selected candidates were verified by Real-time Quantitative PCR and luciferase reporter assay.</p><p><strong>Results: </strong>The results of MMSE and MoCA scores showed that patients in both the control (conventional treatment) group and HBO therapy group had significantly higher post-treatment cognitive scores, and in the 6th month after treatment, patients in the HBO group had higher scores than those in the control group. Blood inflammatory factors showed similar results, with the HBO group having higher anti-inflammatory factors IL-4 and IL-10 than the control group, and lower pro-inflammatory factors IL-2, IL-6, TNF-α, IFN-α and IL-17A than the control group. We further identified a competitive endogenous RNA regulator network of LINC00205-hsa-miR-495-3p-TNFSF15 involved in the HBO treatment, and their expression patterns were verified by qRT-PCR.</p><p><strong>Conclusion: </strong>HBO treatment can improve the cognitive performance of PSCI patients in comparison to conventional treatment scheme. LINC00205/miR-495-3p/TNFSF15 axis may be responsible for the treatment effect of HBO therapy.</p>","PeriodicalId":51142,"journal":{"name":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","volume":"62 1","pages":"11-19"},"PeriodicalIF":1.0000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11877386/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Noropsikiyatri Arsivi-Archives of Neuropsychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.29399/npa.28530","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: We investigated the effects of hyperbaric oxygen (HBO) therapy on post-stroke cognitive impairment (PSCI) and performed the differential profiling of lncRNAs and mRNA.
Methods: The serum levels of different inflammatory factors were detected in PSCI patients with or without HBO therapy. The cognitive functions of patients in different groups were assessed before and after treatment. Differential expression analysis was performed on lncRNAs and mRNAs, followed by functional interaction prediction. The selected candidates were verified by Real-time Quantitative PCR and luciferase reporter assay.
Results: The results of MMSE and MoCA scores showed that patients in both the control (conventional treatment) group and HBO therapy group had significantly higher post-treatment cognitive scores, and in the 6th month after treatment, patients in the HBO group had higher scores than those in the control group. Blood inflammatory factors showed similar results, with the HBO group having higher anti-inflammatory factors IL-4 and IL-10 than the control group, and lower pro-inflammatory factors IL-2, IL-6, TNF-α, IFN-α and IL-17A than the control group. We further identified a competitive endogenous RNA regulator network of LINC00205-hsa-miR-495-3p-TNFSF15 involved in the HBO treatment, and their expression patterns were verified by qRT-PCR.
Conclusion: HBO treatment can improve the cognitive performance of PSCI patients in comparison to conventional treatment scheme. LINC00205/miR-495-3p/TNFSF15 axis may be responsible for the treatment effect of HBO therapy.
期刊介绍:
Archives of Neuropsychiatry (Arch Neuropsychiatry) is the official journal of the Turkish Neuropsychiatric Society. It is published quarterly, and four editions annually constitute a volume.
Archives of Neuropsychiatry is a peer reviewed scientific journal that publishes articles on psychiatry, neurology, and behavioural sciences. Both clinical and basic science contributions are welcomed. Submissions that address topics in the interface of neurology and psychiatry are encouraged. The content covers original research articles, reviews, letters to the editor, and case reports.